Docket Number:10A-970708
Inventor:Jyh-Yih Chen
IP Status:TW I377950
Abstract:
Epinecidin-1, a synthetic 21-mer antimicrobial peptide originally identified from grouper (Epinephelus coioides), specifically exhibited high antimicrobial activities against both gram-negative and -positive bacteria. Herein we report on the in vitro cytotoxicity of the peptide, an important step before it can be considered in further applications in cancer therapy. The cytotoxicity of epinecidin-1 was investigated against several cancer cells and normal cells with the MTT assay, and the inhibition of the ability of cancer cells to grow was confirmed by a soft agar assay and scanning electron microscopy. However, cell variations were detected by AO/EtBr staining, and apoptosis and necrosis gene expressions in HT1080 cells after treatment with the epinecidin-1 peptide and Nec-1 showed that epinecidin-1 had an anti-necrosis function in HT1080 cells. The data presented here indicate that epinecidin-1 has in vitro antitumor activity against the HT1080 cell line, and functions like lytic peptides. Moreover, our results suggest that epinecidin-1 may prove to be an effective chemotherapeutic agent for human fibrosarcoma cells in the future.
Fields of Application:
Cancer therapy.
Advantages when compared to the existing technologies:
- Low dosages epinecidin-1 used can effectively to kill cancer cell by membrane disrupt.
- This effect represents a potential use for epinecidin-1 as a topical agent treated intradermal and epithelial skin cancers.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
